Lawmakers ask FDA to outline Covid-19 vaccine approval process
Key Democratic members in the US House of Representatives have called on FDA commissioner Stephen Hahn to brief their staff on how the agency plans to make decisions regarding the development, review and deployment of vaccines against the novel coronavirus SARS-CoV-2.
In a letter dated June 18, Rep. Carolyn Maloney (D-NY), chairwoman of the House Committee on Oversight and Reform, Rep. Raja Krishnamoorthi (D-IL), chairman of the committee’s Subcommittee on Economic and Consumer Policy, along with Rep. James Clyburn (D-SC), chairman of the Select Subcommittee on the Coronavirus Crisis, offered suggestions as to how Hahn could improve public confidence in any Covid-19 vaccines his agency might authorize. They also invited the commissioner to brief their staff on the topic on July 2.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.